Using DNA devices to track anticancer drug activity.

about

Advantages of an optical nanosensor system for the mechanistic analysis of a novel topoisomerase I targeting drug: a case study.Radiation interactions with biological systems.Application of Electrochemical Devices to Characterize the Dynamic Actions of Helicases on DNA.

P2860

Q31155008-E779AA22-94C3-4F68-9847-5B7A18964FBA Q39100816-94008D0C-678D-42D8-94FC-7188C7FCC82D Q48333068-711CF3B7-5E08-459C-A37A-1B5E97ED8458

P2860

Using DNA devices to track anticancer drug activity.

Item

http://www.wikidata.org/entity/Q38792004

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Using DNA devices to track anticancer drug activity.

@en

type

Item

label

Using DNA devices to track anticancer drug activity.

@en

prefLabel

Using DNA devices to track anticancer drug activity.

@en

P1476

Using DNA devices to track anticancer drug activity

@en

P2093

David A Boothman

http://www.w3.org/2001/XMLSchema#string

Dimithree Kahanda

http://www.w3.org/2001/XMLSchema#string

Gaurab Chakrabarti

http://www.w3.org/2001/XMLSchema#string

Marc A Mcwilliams

http://www.w3.org/2001/XMLSchema#string

P2860

Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways

NQO1 stabilizes p53 through a distinct pathway.

Iron transport and storage.

Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.

Multiplexed DNA-modified electrodes

Electrochemical approach of anticancer drugs--DNA interaction.

Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone.

An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis

Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers

P304

647-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOS.2016.02.026

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason D Slinker

P577

2016-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26901461

http://www.w3.org/2001/XMLSchema#string

P932

4793915

http://www.w3.org/2001/XMLSchema#string

Using DNA devices to track anticancer drug activity.

about

P2860

P2860

Using DNA devices to track anticancer drug activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932